1.Establishment of interfering RNA library of acetyltransferase genes and its infection of HepG2.2.15 cells
Fengdi LI ; Kehui LIU ; Haiqing WU ; Weikiang TANG ; Gangde ZHAO ; Xiaogang XIANG ; Yumin XU ; Qing XIE ; Hui WANG
Chinese Journal of Infectious Diseases 2014;(11):649-652
Objective To construct lentivirus vectors carrying 16 short hairpin RNA (shRNA) expression cassettes targeting histone acetyltransferases and provide a powerful research approach to explore the mechanism of epigenetic genes in regulating hepatitis B virus (HBV).Methods Following the rule of short shRNA primer design,eight-pair primers (A ~ H )for each gene,which had stable interfering efficiency,were designed.The annealed primers were connected to the empty lentiviral vectors of shRNA for transformation.In order to confirm the positive clones,clones were analyzed by real-time polymerase chain reaction (RT-PCR ).Then, qualified plasmids were verified by enzyme digestion technology.Four shRNA lentivirus plasmids against the same gene were mixed to build lentivirus respectively.After the virus transfected into 293T cells for 48 and 72 hours,supernatants were collected to infect HepG2.2.15 cells.The percentage of fluorescent cells were observed and assessed by microscope 72 hours after infection.Results One hundred and twenty-eight lentiviral vectors of RNA interference (RNAi)library were constructed against 16 histone acetyltransferases and more than 80% of HepG2.2.15 cells were infected with lentivirus 72 hours after infection.Conclusions Sixteen shRNA lentivirus vectors against histone acetyltransferase are successfully constructed.Thus,a solid foundation for the study of the effect of human histone deacetylase on HBV replication is established.
2.A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening.
Chang ZHANG ; Yang WU ; Yuna SUN ; Chuan HONG ; Kehui XIANG ; Yu GUO ; Mark BARTLAM ; Zhiyong LOU
Protein & Cell 2010;1(3):284-290
Current in vitro assays for the activity of HIV-RT (reverse transcriptase) require radio-labeled or chemically modified nucleotides to detect reaction products. However, these assays are inherently end-point measurements and labor intensive. Here we describe a novel non-radioactive assay based on the principle of pyrosequencing coupled-enzyme system to monitor the activity of HIV-RT by indirectly measuring the release of pyrophosphate (PP(i)), which is generated during nascent strand synthesis. The results show that our assay could monitor HIV-RT activity with high sensitivity and is suitable for rapid high-throughput drug screening targeting anti-HIV therapies due to its high speed and convenience. Moreover, this assay can be used to measure primase activity in an easy and sensitive manner, which suggests that this novel approach could be wildly used to analyze the activity of PP(i)-generated and ATP-free enzyme reactions.
Anti-HIV Agents
;
pharmacology
;
Colorimetry
;
Diphosphates
;
analysis
;
metabolism
;
Drug Evaluation, Preclinical
;
HIV
;
drug effects
;
enzymology
;
HIV Reverse Transcriptase
;
analysis
;
antagonists & inhibitors
;
metabolism
;
Humans
;
In Vitro Techniques
;
Nevirapine
;
pharmacology
;
Reverse Transcriptase Inhibitors
;
pharmacology
;
Sequence Analysis, DNA
;
Thymine Nucleotides
;
metabolism